TJ101
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TJ101, covering 2024-04-15 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors [Phase 1]